BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22563673)

  • 41. The landscape of myeloid neoplasms with isochromosome 17q discloses a specific mutation profile and is characterized by an accumulation of prognostically adverse molecular markers.
    Meggendorfer M; Haferlach C; Zenger M; Macijewski K; Kern W; Haferlach T
    Leukemia; 2016 Jul; 30(7):1624-7. PubMed ID: 26859077
    [No Abstract]   [Full Text] [Related]  

  • 42. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia.
    Mori N; Yoshinaga K; Tomita K; Ohwashi M; Kondoh T; Shimura H; Wang YH; Shiseki M; Okada M; Motoji T
    Leuk Res; 2011 Apr; 35(4):516-21. PubMed ID: 20828818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.
    Thol F; Friesen I; Damm F; Yun H; Weissinger EM; Krauter J; Wagner K; Chaturvedi A; Sharma A; Wichmann M; Göhring G; Schumann C; Bug G; Ottmann O; Hofmann WK; Schlegelberger B; Heuser M; Ganser A
    J Clin Oncol; 2011 Jun; 29(18):2499-506. PubMed ID: 21576631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extracellular vesicles from myelodysplastic mesenchymal stromal cells induce DNA damage and mutagenesis of hematopoietic stem cells through miRNA transfer.
    Meunier M; Guttin A; Ancelet S; Laurin D; Zannoni J; Lefebvre C; Tondeur S; Persoons V; Pezet M; Pernet-Gallay K; Chuffart F; Rousseaux S; Testard Q; Thevenon J; Jouzier C; Deleuze JF; Laulagnier K; Sadoul R; Chatellard C; Hainaut P; Polack B; Cahn JY; Issartel JP; Park S
    Leukemia; 2020 Aug; 34(8):2249-2253. PubMed ID: 32051530
    [No Abstract]   [Full Text] [Related]  

  • 45. [Methylation status of ZO-1 gene in patients with myelodysplastic syndrome].
    Kang HY; Wang C; Dou LP; Qing Y; Han XP; Sun JF; Liu CH; Lu XC; Liu Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):70-3. PubMed ID: 18315903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance of methylation status of zo-1 gene in differential diagnosis for myelodysplastic syndrome].
    Kang HY; Wang XR; Wang LL; Wang C; Cen J; Gao L; Liu Y; Li YH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):76-80. PubMed ID: 21362226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
    Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
    Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant methylation of death-associated protein kinase 1 CpG islands in myelodysplastic syndromes.
    Wu X; Liu W; Tian Y; Xiao M; Wu Y; Li C
    Acta Haematol; 2011; 125(4):179-85. PubMed ID: 21212658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia.
    Li MY; Xu YY; Kang HY; Wang XR; Gao L; Cen J; Wang W; Wang N; Li YH; Wang LL; Yu L
    Chin Med J (Engl); 2015 Aug; 128(15):2019-25. PubMed ID: 26228212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p15INK4b methylation correlates with thrombocytopenia, blast percentage, and survival in myelodysplastic syndromes in a dose dependent manner: quantitation using pyrosequencing study.
    Kim M; Oh B; Kim SY; Park HK; Hwang SM; Kim TY; She CJ; Yang I; Yoon SS; Yoon JH; Lee DS
    Leuk Res; 2010 Jun; 34(6):718-22. PubMed ID: 19782398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome.
    Zhang TJ; Zhou JD; Yang DQ; Wang YX; Yao DM; Ma JC; Wen XM; Guo H; Lin J; Qian J
    Clin Chem Lab Med; 2016 May; 54(5):865-71. PubMed ID: 26485746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.
    Xu F; Liu L; Chang CK; He Q; Wu LY; Zhang Z; Shi WH; Guo J; Zhu Y; Zhao YS; Gu SC; Fei CM; Li X
    Oncotarget; 2016 Feb; 7(7):8119-30. PubMed ID: 26812882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome.
    Qian J; Yao DM; Lin J; Wang YL; Han LX; Xu WR; Wu CY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):74-81. PubMed ID: 19196380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
    Yang Y; Zhang Q; Xu F; Chang C; Li X
    Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Epigenetic alterations in myelodysplastic syndromes].
    Xu F; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):531-5. PubMed ID: 20416204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased AF1q gene expression in high-risk myelodysplastic syndrome.
    Tse W; Deeg HJ; Stirewalt D; Appelbaum FR; Radich J; Gooley T
    Br J Haematol; 2005 Jan; 128(2):218-20. PubMed ID: 15638856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and methylation status of MDR-1 gene in pediatric primary myelodysplastic syndrome.
    Ferreira Rodrigues E; Lamim Lovatel V; Sobral da Costa E; Mencalha AL; Abdelhay E; de Souza Fernandez T
    Pediatr Blood Cancer; 2017 Jan; 64(1):209-210. PubMed ID: 27605311
    [No Abstract]   [Full Text] [Related]  

  • 58. Aberrant hypomethylation of SALL4 gene is associated with intermediate and poor karyotypes in acute myeloid leukemia.
    Ma JC; Qian J; Lin J; Qian W; Yang J; Wang CZ; Chai HY; Li Y; Chen Q; Qian Z
    Clin Biochem; 2013 Mar; 46(4-5):304-7. PubMed ID: 23201546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts.
    Valencia A; Cervera J; Such E; Ibañez M; Gómez I; Luna I; Senent L; Oltra S; Sanz MA; Sanz GF
    Leuk Res; 2011 Apr; 35(4):479-83. PubMed ID: 20864173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.
    Xu F; Yang R; Wu L; He Q; Zhang Z; Zhang Q; Yang Y; Guo J; Chang C; Li X
    Cancer Lett; 2012 Apr; 317(1):33-40. PubMed ID: 22120066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.